Page last updated: 2024-11-01

ofloxacin and Kidney Stones

ofloxacin has been researched along with Kidney Stones in 4 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Research Excerpts

ExcerptRelevanceReference
"Ofloxacin was used in the empirical and etiotropic therapy of patients with severe urinary tract infection."2.68[Outlook and experience in using ofloxacin in urology]. ( Derevianko, II; Kotliarova, GA; Siniukhin, VN, 1996)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doğan, HS1
Sahin, A1
Cetinkaya, Y1
Akdoğan, B1
Ozden, E1
Kendi, S1
Ilker, Y1
Türkeri, LN1
Korten, V1
Tarcan, T1
Akdaş, A1
Derevianko, II1
Kotliarova, GA1
Siniukhin, VN1
Fujita, K1
Mizuno, T1
Ushiyama, T1
Suzuki, K1
Hadano, S1
Satoh, S1
Kambayashi, T1
Mugiya, S1
Nakano, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Neutrophil and Lymphocyte Counts and the Neutrophil-to-lymphocyte Ratio as a Predictor of Fever Following Percutaneous Nephrolithotomy in Patients Without Risk Factors[NCT03774940]519 participants (Actual)Interventional2005-01-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

4 trials available for ofloxacin and Kidney Stones

ArticleYear
Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients.
    Journal of endourology, 2002, Volume: 16, Issue:9

    Topics: Adult; Antibiotic Prophylaxis; Bacteriuria; Dose-Response Relationship, Drug; Drug Administration Sc

2002
Antimicrobial prophylaxis in management of urinary tract stones by extracorporeal shock-wave lithotripsy: is it necessary?
    Urology, 1995, Volume: 46, Issue:2

    Topics: Adult; Bacteriuria; Female; Humans; Incidence; Kidney Calculi; Lithotripsy; Male; Ofloxacin; Premedi

1995
[Outlook and experience in using ofloxacin in urology].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1996, Volume: 41, Issue:9

    Topics: Administration, Oral; Anti-Infective Agents, Urinary; Drug Administration Schedule; Forecasting; Gra

1996
Complicating risk factors for pyelonephritis after extracorporeal shock wave lithotripsy.
    International journal of urology : official journal of the Japanese Urological Association, 2000, Volume: 7, Issue:6

    Topics: Adolescent; Adult; Age Distribution; Aged; Anti-Infective Agents, Urinary; Bacteriuria; Humans; Kidn

2000